THE MECHANISM OF SMAD4 INHIBITING EMT AND METASTASIS OF COLORECTAL CANCER

被引:0
|
作者
Zheng, Guangwei [1 ]
Zheng, Jiantao [2 ]
Fang, Zhipeng [1 ]
Zhou, Yi [1 ]
Lin, Zhenlv [1 ]
机构
[1] Fujian Med Univ, Affiliated Hosp 1, Dept Surg Emergency, Fuzhou 350005, Fujian, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Fuzhou 350005, Fujian, Peoples R China
来源
ACTA MEDICA MEDITERRANEA | 2022年 / 38卷 / 02期
关键词
Smad4; colorectal cancer; EMT; invasion and metastasis; EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; TGF-BETA; IN-VITRO; EXPRESSION; CELLS; MIGRATION; RESECTION;
D O I
10.19193/0393-6384_2022_2_211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: To explore the role of Smad4 silencing in epithelial-mesenchymal transition (EMT) of colorectal cancer (CRC) cells and its possible involvement in invasion and metastasis signaling pathways. Materials and methods: CRC SW480 cells were transfected with lentiviral particles containing resistant control shRNA and Smad4 shRNA, and the transfected cells were divided into Smad4 silencing group (shRNA-Smad4) and blank control group (NC). Smad4 protein and mRNA levels were determined by western blot and real-time quantitative polymerase chain reaction (RT-qPCR). The cells were treated with 5 ng/ml TGF-I31 for 0 and 48 h, and cell migration and invasion in vitro were measured by wound healing and Transwell assays, respectively. The PCR was used to determine the levels of EMT-related proteins and MMP-9 protein and mRNA. Results: Compared with the control group, Smad4 protein and mRNA levels in Smad4-silenced cells were significantly reduced (P<0.05), and a stable Smad4-silenced cell line was successfully established. After the action of TGF-I31, compared with the control group, cell migration and invasion of the shRNA-Smad4 group were significantly enhanced; E-cadherin mRNA levels significantly decreased, and the mRNA levels of Vimentin, Snail, Twist1 and MMP-9 significantly increased (P<0.05). Conclusion: Smad4 silencing can promote EMT of CRC SW480 cells, thereby enhancing cell invasion and metastasis, which may be related to the transcriptional regulation on Snail and Twist1 expression.
引用
收藏
页码:1389 / 1395
页数:7
相关论文
共 50 条
  • [31] Tranilast inhibits TGF-beta-induced EMT and invasion/metastasis via the suppression of smad4 in lung cancer cell lines
    Takahashi, K.
    Nishikawa, S.
    Miyata, R.
    Noguchi, M.
    Ishikawa, H.
    Yutaka, Y.
    Nakajima, D.
    Hamaji, M.
    Ohsumi, A.
    Menju, T.
    Chen-Yoshikawa, F.
    Sato, T.
    Sonobe, M.
    Date, H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [32] Loss of SMAD4 Alters BMP Signaling to Promote Colorectal Cancer Cell Metastasis via Activation of Rho and ROCK
    Voorneveld, Philip W.
    Kodach, Liudmila L.
    Jacobs, Rutger J.
    Liv, Nalan
    Zonnevylle, A. Christiaan
    Hoogenboom, Jacob P.
    Biemond, Izak
    Verspaget, Hein W.
    Hommes, Daniel W.
    de Rooij, Karien
    van Noesel, Carel J. M.
    Morreau, Hans
    van Wezel, Tom
    Offerhaus, G. Johan A.
    van den Brink, Gijs R.
    Peppelenbosch, Maikel P.
    ten Dijke, Peter
    Hardwick, James C. H.
    GASTROENTEROLOGY, 2014, 147 (01) : 196 - U328
  • [33] SMAD4 loss is associated with poor prognosis in Middle Eastern colorectal cancer
    Ahmed, Maqbool
    Siraj, Abdul K.
    Masoodi, Tariq
    Bu, Rong
    Al-Dayel, Fouad
    Al-Kuraya, Khawla S.
    CANCER RESEARCH, 2017, 77
  • [34] A Meta-Analysis of SMAD4 Immunohistochemistry as a Prognostic Marker in Colorectal Cancer
    Voorneveld, Philip W.
    Jacobs, Rutger J.
    Kodach, Liudmila L.
    Hardwick, James C. H.
    TRANSLATIONAL ONCOLOGY, 2015, 8 (01) : 18 - 24
  • [35] Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4
    Ouahoud, Sarah
    Jacobs, Rutger J.
    Kodach, Ludmilla L.
    Voorneveld, Philip W.
    Hawinkels, Lukas J. A. C.
    Weil, Nikki L.
    van Vliet, Britt
    Herings, Ron M.
    Van der Burg, Lennart R. A.
    van Wezel, Tom
    Morreau, Hans
    Slingerland, Marije
    Bastiaannet, Esther
    Putter, Hein
    Hardwick, James C. H.
    BRITISH JOURNAL OF CANCER, 2022, 126 (02) : 297 - 301
  • [36] Smad4 re-expression increases the sensitivity to parthenolide in colorectal cancer
    Li, Xuemei
    Yang, Huike
    Ke, Jia
    Liu, Baoquan
    Lv, Xiaohong
    Li, Xinlei
    Zhang, Yafang
    ONCOLOGY REPORTS, 2017, 38 (04) : 2317 - 2324
  • [37] SMAD4 mutations do not preclude epithelial–mesenchymal transition in colorectal cancer
    Patrick Frey
    Antoine Devisme
    Katja Rose
    Monika Schrempp
    Vivien Freihen
    Geoffroy Andrieux
    Melanie Boerries
    Andreas Hecht
    Oncogene, 2022, 41 : 824 - 837
  • [38] Integrated multi-omics characterization of SMAD4 mutant colorectal cancer
    Zhao, Danyi
    Qu, Yanjun
    Gao, Na
    Wu, Tao
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [39] Statin use is associated with a reduced incidence of colorectal cancer expressing SMAD4
    Sarah Ouahoud
    Rutger J. Jacobs
    Ludmilla L. Kodach
    Philip W. Voorneveld
    Lukas J. A. C. Hawinkels
    Nikki L. Weil
    Britt van Vliet
    Ron M. Herings
    Lennart R. A. van der Burg
    Tom van Wezel
    Hans Morreau
    Marije Slingerland
    Esther Bastiaannet
    Hein Putter
    James C. H. Hardwick
    British Journal of Cancer, 2022, 126 : 297 - 301
  • [40] Molecular and immunohistochemical analysis of Smad4 in colorectal adenocarcinomas
    Jia, Xu
    Katkoori, Venkat R.
    Jhala, Nirag C.
    Callens, Tom
    Messiaen, Ludwine
    Herring, Courtney B.
    Posey, James, III
    Grizzle, William E.
    Manne, Upender
    CANCER RESEARCH, 2006, 66 (08)